Lupin gets warning letter from USFDA for Tarapur API plant in Maharashtra

Q: How long will it take to read this news story?

The story "Lupin gets warning letter from USFDA for Tarapur API plant in Maharashtra" has 311 words across 1 sentences, which will take approximately 2 - 3 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Lupin gets warning letter from USFDA for Tarapur API plant in Maharashtra" was covered 4 months ago by Business Standard, a news publisher based in India.

Q: How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news. The outlet is headquartered in India and publishes an average of 108 news stories per day. It's most recent story was published 3 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Negative, indicating that people regard this as "bad news".

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #620733</li><li>URL: https://beamstart.com/news/lupin-gets-warning-letter-from-16644604576755</li></ul>

Business Standard Logo Business Standard 4 mo ago

Lupin gets warning letter from USFDA for Tarapur API plant in Maharashtra - Business Standard

Quick Summary:

Drug firm Lupin on Thursday said it has received a warning letter from the US health regulator for its Tarapur-based manufacturing facility in Maharashtra.

"The company does not believe that the warning letter will have an impact on disruption of supplies or the existing revenues from operations of this facility," the Mumbai-based company said in a regulatory filing.

The drug firm is committed to addressing the concerns raised by the USFDA and will work with the agency to resolve the issues at the earliest, it added.